drugset / Trial / NCT00382096

Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes

NCT00382096

Phase 3 Completed 1179 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of a fixed combination of vildagliptin and metformin in lowering blood glucose in patients with type 2 diabetes

Timeline

Start
2006-09
Primary completion
2008-06-03
Completion
2008-06-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule
Subject Vildagliptin Other / unclassified